Resources

Experience. Personal attention. Value.

These are just some of the qualities that set us apart from the competition. The best thing is that you don't need to sacrifice peace of mind using our products – they've been time-tested for more than 30 years.

Quant-Rho^® FITC Anti-D is used for quantifying a Fetal Maternal Hemorrhage (FMH) by in vitro labeling of RhD positive cells for analysis by flow cytometry. This FITC anti-D provides a rapid method for the determination of the total number of fetal RhD positive cells in a maternal RhD negative sample. Quant-Rho® FITC anti-D has the advantage of providing more accurate and reproducible results than those obtained from the Kleihauer-Betke test. It only detects RhD positive cells making it particularly useful in patients with high levels of Hemoglobin F (HbF).

Package Insert – pdf download

Benefits Quantifies FMH quickly and accurately Standardized methodology Reproducible results Does not detect HbF 100 tests per vial

Features For use by flow cytometry Ready for use reagents Reagents stable for 2 years FITC labeled anti-D (LDG76) monoclonal antibody Supplied in 5mL vials

Additional specialty products are currently being developed or are under review by the FDA.

For quick answers to many product questions, take a look at our Technical FAQs.